Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Other financing activities (2018)

Historic Other financing activities for Corcept Therapeutics (CORT) over the last 4 years, with Q1 2018 value amounting to -$54000.0.

  • Corcept Therapeutics' Other financing activities changed N/A to -$54000.0 in Q1 2018 from the same period last year, while for Mar 2011 it was $239.9 million, marking a year-over-year increase of 3834.84%. This contributed to the annual value of -$293000.0 for FY2017, which is N/A changed from last year.
  • According to the latest figures from Q1 2018, Corcept Therapeutics' Other financing activities is -$54000.0.
  • Corcept Therapeutics' Other financing activities' 5-year high stood at -$54000.0 during Q1 2018, with a 5-year trough of -$54000.0 in Q1 2018.